Pharming (PHAR) Other financing activities (2019 - 2026)

Pharming (PHAR) has 8 years of Other financing activities data on file, last reported at -$7.9 million in Q2 2026.

• Quarterly Other financing activities changed N/A year-over-year to -$7.9 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$22.2 million (changed N/A YoY) and the FY2025 annual result came in at -$285000.0, changed N/A from the prior year.
• Other financing activities retreated to -$7.9 million in Q2 2026, from -$5.9 million in the prior quarter.
• In the past five years, Other financing activities ranged from a high of $253000.0 in Q3 2022 to a low of -$8.1 million in Q3 2025.
• A 5-year average of -$2.8 million and a median of -$250500.0 in 2023 frame the typical range for Other financing activities.
• Annual changes were most pronounced in 2022 — Other financing activities surged 1330.24% — and 2025, when it sank 1576.47%.
• Tracing PHAR's Other financing activities over 5 years: stood at -$20000.0 in 2022, then tumbled by 980.0% to -$216000.0 in 2023, then soared by 92.13% to -$17000.0 in 2024, then slumped by 1576.47% to -$285000.0 in 2025, then plunged by 2685.26% to -$7.9 million in 2026.
• The last three Other financing activities figures came in at -$7.9 million (Q2 2026), -$5.9 million (Q1 2026), and -$285000.0 (Q4 2025), per Business Quant data.